|
Index of reports
> All cases (547)
> Cases with Nausea (72)
Below is the selection of adverse event reports related to Rebetol (Ribavirin) that includes all cases where reactions include nausea.
Reports 1 - 25 of 72 Next >>
Adverse event in 49 year old female receiving Rebetol (Ribavirin)
Reported by a consumer/non-health professional from United States on 2007-10-31
Patient: 49 year old female, weighing 74.8 kg (164.7 pounds)
Adverse reactions / side effects: Agitation, Oral Intake Reduced, Drug Ineffective, Visual Acuity Reduced, Headache, Pyrexia, Constipation, Fall, Abdominal Discomfort, Fatigue, Photophobia, Abdominal Distension, Depression, Vomiting, Nausea, Paraesthesia, Haematochezia, Insomnia, Alopecia, Dehydration, Anorexia, Memory Impairment, Lacrimation Increased, Asthenia
Suspect drug(s):
PEG-Intron
Dosage: 120 mcg;qw;sc
Indication: Hepatitis C
Start date: 2007-08-07
Rebetol
Dosage: 1000 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-08-07
Other drugs received by patient: Laxatives
Adverse event in 51 year old female receiving Rebetol (Ribavirin)
Reported by a consumer/non-health professional from United States on 2007-10-29
Patient: 51 year old female, weighing 81.6 kg (179.6 pounds)
Adverse reactions / side effects: Weight Decreased, Hepatic Pain, Vomiting, Nausea, Pain in Extremity, Pain, Pleurisy, Hepatic Neoplasm, Food Aversion, Weight Fluctuation, Decreased Appetite, Influenza Like Illness
Suspect drug(s):
PEG-Intron
Dosage: ; sc
Indication: Hepatitis C
Start date: 2007-07-06
Rebetol
Dosage: ; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-07-06
Adverse event in 57 year old male receiving Rebetol (Ribavirin)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-26
Patient: 57 year old male
Adverse reactions / side effects: Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Vomiting, Nausea, Alanine Aminotransferase Increased, Blood Albumin Increased, Fatigue, Aspartate Aminotransferase Increased
Adverse event resulted in: disablity
Suspect drug(s):
PEG-Intron (Peginterron Alfa-2B)
Dosage: 120 mcg;qw; sc
Indication: Hepatitis C
Start date: 2007-03-13
End date: 2007-06-26
Rebetol
Dosage: 140 0mg;qd;po; 1000 mg;qd;po; 800 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-03-13
End date: 2007-03-25
Rebetol
Dosage: 140 0mg;qd;po; 1000 mg;qd;po; 800 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-03-13
End date: 2007-06-26
Rebetol
Dosage: 140 0mg;qd;po; 1000 mg;qd;po; 800 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-03-26
End date: 2007-06-26
Rebetol
Indication: Hepatitis C
HCV-796
Dosage: 500 mg;bid;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-03-13
End date: 2007-06-26
Other drugs received by patient: Vicodin; Folic Acid; Advil; Albuterol; Youngevity Vitamin Supplements with Selenium
Adverse event in 49 year old male receiving Rebetol (Ribavirin)
Reported by a consumer/non-health professional from United States on 2007-10-24
Patient: 49 year old male, weighing 86.2 kg (189.6 pounds)
Adverse reactions / side effects: Eye Irritation, Schizophrenia, Headache, Hyperhidrosis, Delusion, Mania, Thinking Abnormal, Fatigue, Neck Pain, Palpitations, Depression, Blood Sodium Decreased, Localised Infection, Back Pain, Vomiting, Mydriasis, Nausea, Paranoia, DRY Skin, Convulsion, Bipolar Disorder, Hyperphagia, Insomnia, Thyroid Disorder, Feeling Abnormal
Adverse event resulted in: hospitalization
Suspect drug(s):
PEG-Intron
Dosage: ; sc
Indication: Hepatitis C
Start date: 2007-04-10
End date: 2007-06-04
Rebetol
Dosage: ; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-04-10
End date: 2007-06-04
Adverse event in 42 year old male receiving Rebetol (Ribavirin)
Reported by a consumer/non-health professional from United States on 2007-10-22
Patient: 42 year old male
Adverse reactions / side effects: Nausea, Skin Exfoliation, DRY Skin, Haematemesis, Rash Macular, Skin Fissures, Skin Discolouration, Chest Pain, Pharyngolaryngeal Pain, Epistaxis, Decreased Appetite
Suspect drug(s):
PEG-Intron
Indication: Hepatitis C
Start date: 2007-08-16
Rebetol
Dosage: po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-08-16
Adverse event in 57 year old male receiving Rebetol (Ribavirin)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-22
Patient: 57 year old male
Adverse reactions / side effects: Jaundice, Blood Bilirubin Increased, Blood Alkaline Phosphatase Increased, Vomiting, Nausea, Alanine Aminotransferase Increased, Blood Albumin Increased, Fatigue, Aspartate Aminotransferase Increased
Adverse event resulted in: disablity
Suspect drug(s):
PEG-Intron
Dosage: 120 mgc; qw; sc
Indication: Hepatitis C
Start date: 2007-03-13
End date: 2007-06-26
Rebetol
Dosage: 1400 mg; qd; po; 1000 mg; qd; po; 800 mg; qd; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-03-13
End date: 2007-03-25
Rebetol
Dosage: 1400 mg; qd; po; 1000 mg; qd; po; 800 mg; qd; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-03-26
End date: 2007-03-28
Rebetol
Dosage: 1400 mg; qd; po; 1000 mg; qd; po; 800 mg; qd; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-03-29
End date: 2007-06-26
HCV-796
Dosage: 500 mg; bid; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-03-13
End date: 2007-06-26
Other drugs received by patient: Vicodin (Con.); Folic Acid (Con.); Advil / 00109201 / (Con.); Albuterol (Con.); Youngevity Vitamin Supplements with Slenium (Con.)
Adverse event in 57 year old male receiving Rebetol (Ribavirin)
Reported by a physician from United States on 2007-10-19
Patient: 57 year old male
Adverse reactions / side effects: Blood Bilirubin Increased, Jaundice, Extrasystoles, Blood Thyroid Stimulating Hormone Increased, Fall, Liver Disorder, Road Traffic Accident, Fatigue, TRI-Iodothyronine Decreased, Dizziness, Emotional Disorder, Depression, Vomiting, Nausea, Alanine Aminotransferase Increased, Thyroxine Increased, Tremor, Anxiety, Aspartate Aminotransferase Increased
Adverse event resulted in: disablity
Suspect drug(s):
PEG-Intron
Dosage: 150 mcg;qw;sc
Indication: Hepatitis C
Start date: 2007-02-22
End date: 2007-07-03
Rebetol
Dosage: 1400 mg;qd;po; 1000 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-02-22
End date: 2007-03-21
Rebetol
Dosage: 1400 mg;qd;po; 1000 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-03-21
End date: 2007-07-09
HCV-796
Dosage: 500 mg;bid;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-02-22
End date: 2007-07-03
Other drugs received by patient: Omeprazole; Allopurinol; Atenolol; Levothyroxine Sodium; Lorazepam; Folic Acid; Fentanyl; Compazine
Adverse event in 35 year old female receiving Rebetol (Ribavirin)
Reported by a physician from United States on 2007-10-18
Patient: 35 year old female
Adverse reactions / side effects: Thrombosis, Nasopharyngitis, Vomiting, Nausea, Urinary Tract Infection, Drug Exposure Before Pregnancy, Pulmonary Thrombosis, Sinusitis, Pregnancy, Intracardiac Thrombus
Suspect drug(s):
PEG-Intron
Dosage: 150 mcg; qw; sc
Indication: Hepatitis C
Start date: 2006-05-01
End date: 2006-10-01
Rebetol
Dosage: 1000 mg; qd; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2006-05-01
End date: 2006-10-01
Other drugs received by patient: Vicodin; Valtrex; Advair Diskus 100 / 50; Coumadin; Lovenox; Amoxicillin; Phenergan HCL; Mucinex; Sudafed 12 Hour; Macrobid; Ambien
Adverse event in 53 year old male receiving Rebetol (Ribavirin)
Reported by a consumer/non-health professional from United States on 2007-10-17
Patient: 53 year old male, weighing 68.0 kg (149.7 pounds)
Adverse reactions / side effects: Weight Decreased, Economic Problem, Chills, Blood Count Abnormal, Hyperhidrosis, Haematemesis, Fatigue, Feeling Hot, Pharyngolaryngeal Pain, Depression, Stevens-Johnson Syndrome, Hypersomnia, Vomiting, Nausea, Drug Hypersensitivity, Breast Mass, Dysgeusia, Abdominal Mass, Sleep Disorder, Diarrhoea, Anorexia, Asthenia, Scar
Suspect drug(s):
PEG-Intron
Dosage: 120 mcg;qw;sc
Indication: Hepatitis C
Start date: 2007-01-09
End date: 2007-01-13
PEG-Intron
Dosage: 120 mcg;qw;sc
Indication: Hepatitis C
Start date: 2007-07-17
Rebetol
Dosage: 1000 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-01-09
End date: 2007-01-13
Adverse event in 57 year old male receiving Rebetol (Ribavirin)
Reported by a physician from United States on 2007-10-11
Patient: 57 year old male
Adverse reactions / side effects: Blood Bilirubin Increased, Jaundice, Vomiting, Nausea, Extrasystoles, Alanine Aminotransferase Increased, Blood Thyroid Stimulating Hormone Increased, Fall, Tremor, Anxiety, Fatigue, Affect Lability, Road Traffic Accident, TRI-Iodothyronine Decreased, Aspartate Aminotransferase Increased, Dizziness, Depression
Adverse event resulted in: disablity
Suspect drug(s):
PEG-Intron
Dosage: 150 mcg;qw;sc
Indication: Hepatitis C
Start date: 2007-02-22
End date: 2007-07-03
Rebetol
Dosage: 1400 mg;qd;po : 1000 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-02-22
End date: 2007-03-21
Rebetol
Dosage: 1400 mg;qd;po : 1000 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-03-21
End date: 2007-07-09
Other drugs received by patient: Omeprazole; Allopurinol; Atenolol; Levothyroxine Sodium; Lorazepam; Folic Acid; Fentanyl; Compazine
Adverse event in 57 year old male receiving Rebetol (Ribavirin)
Reported by a physician from United States on 2007-10-05
Patient: 57 year old male
Adverse reactions / side effects: Jaundice, Vomiting, Nausea, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Extrasystoles, Dizziness, Depression
Adverse event resulted in: disablity
Suspect drug(s):
PEG-Intron
Dosage: 150 mcg; qw; sc
Indication: Hepatitis C
Start date: 2007-02-22
End date: 2007-07-03
Rebetol
Dosage: 1400 mg; qd; po; 1000 mg; qd; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-02-22
End date: 2007-03-21
Rebetol
Dosage: 1400 mg; qd; po; 1000 mg; qd; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-03-21
End date: 2007-07-09
HCV-796
Dosage: 500 mg; bid; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-02-22
End date: 2007-07-03
Other drugs received by patient: Omeprazole (Con.); Allopurinol (Con.); Atenolol (Con.); Levothyroxine (Con.); Lorazepam (Con.); Folic Acid (Con.); Fentanyl (Con.); Compazine (Con.)
Adverse event in 49 year old female receiving Rebetol (Ribavirin)
Reported by a consumer/non-health professional from United States on 2007-10-05
Patient: 49 year old female
Adverse reactions / side effects: Agitation, Drug Ineffective, Visual Acuity Reduced, Disorientation, Headache, Pyrexia, Constipation, Fall, Faeces Discoloured, Fatigue, Photophobia, Abdominal Distension, Depression, White Blood Cell Count Decreased, Vomiting, Nausea, Stomach Discomfort, Haematochezia, Dehydration, Anorexia, Alopecia, Insomnia, Lacrimation Increased, Memory Impairment
Suspect drug(s):
PEG-Intron
Dosage: sc
Indication: Hepatitis C
Start date: 2007-08-07
Rebetol
Dosage: po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-08-07
Other drugs received by patient: Laxatives (Con.)
Adverse event in 42 year old female receiving Rebetol (Ribavirin)
Reported by a consumer/non-health professional from United States on 2007-10-05
Patient: 42 year old female, weighing 75.3 kg (165.7 pounds)
Adverse reactions / side effects: Bedridden, Economic Problem, Weight Decreased, Contusion, Pruritus, Bile Output Increased, Tooth Infection, Fall, Treatment Noncompliance, Haematemesis, Abdominal Pain Upper, Loss of Consciousness, Impatience, Skin Lesion, DRY Mouth, Depression, Pharyngitis, Crying, Vomiting, Nausea, Dental Caries, Condition Aggravated, Rash, Joint Injury, Joint Sprain, Alopecia, Suicide Attempt, Fluid Intake Reduced, Homicidal Ideation, Asthenia, Hair Colour Changes, Influenza Like Illness
Suspect drug(s):
PEG-Intron
Dosage: sc
Indication: Hepatitis C
Start date: 2006-12-01
Rebetol
Dosage: po
Administration route: Oral
Indication: Hepatitis C
Start date: 2006-12-01
Other drugs received by patient: Metoprolol
Adverse event in 57 year old male receiving Rebetol (Ribavirin)
Reported by a physician from United States on 2007-10-05
Patient: 57 year old male
Adverse reactions / side effects: Blood Bilirubin Increased, Jaundice, Extrasystoles, Fall, Liver Disorder, Fatigue, Malaise, Dizziness, Metabolic Disorder, Depression, Motion Sickness, Vomiting, Nausea, Alanine Aminotransferase Increased, Tremor, Aspartate Aminotransferase Increased
Adverse event resulted in: disablity
Suspect drug(s):
PEG-Intron
Dosage: 150 mcg; qw; sc
Indication: Hepatitis C
Start date: 2007-02-22
End date: 2007-07-03
Rebetol
Dosage: 1400 mg; qd; po, 1000 mg; qd; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-02-22
End date: 2007-03-21
Rebetol
Dosage: 1400 mg; qd; po, 1000 mg; qd; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-03-21
End date: 2007-07-09
HCV-796
Dosage: 500 mg; bid; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-02-22
End date: 2007-07-03
Other drugs received by patient: Omeprazole; Allopurinol; Atenolol; Levothyroxine Sodium; Lorazepam; Folic Acid; Fentanyl; Compazine
Adverse event in 58 year old male receiving Rebetol (Ribavirin)
Reported by a consumer/non-health professional from United States on 2007-10-01
Patient: 58 year old male, weighing 93.4 kg (205.6 pounds)
Adverse reactions / side effects: Weight Decreased, Renal Failure, Vomiting, Diarrhoea, Nausea, Dehydration, Drug Intolerance
Adverse event resulted in: hospitalization
Suspect drug(s):
PEG-Intron
Dosage: 150 mcg; qw; sc
Indication: Hepatitis C
Start date: 2007-08-03
End date: 2007-08-09
Rebetol
Dosage: 1000 mg; qd; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-08-03
End date: 2007-08-09
Other drugs received by patient: Formoterol Fumarate; Tiotropium; Montelukast Sodium; Hydrochlorothiazide; Lisinopril; Azelsatine; Theophylline; Nitroglycerin; Loratadine; Alendronate Sodium; Amlodipine Besylate; Losartan Potassium
Adverse event in 53 year old male receiving Rebetol (Ribavirin)
Reported by a consumer/non-health professional from United States on 2007-07-27
Patient: 53 year old male, weighing 68.0 kg (149.7 pounds)
Adverse reactions / side effects: Weight Decreased, Economic Problem, Chills, Blood Count Abnormal, Hyperhidrosis, Haematemesis, Hot Flush, Fatigue, Pharyngolaryngeal Pain, Depression, Stevens-Johnson Syndrome, Nausea, Mass, Drug Hypersensitivity, Dysgeusia, Diarrhoea, Insomnia, Anorexia, Asthenia, Death of Companion
Suspect drug(s):
PEG-Intron
Dosage: sc
Indication: Hepatitis C
Start date: 2007-01-09
End date: 2007-01-13
PEG-Intron
Dosage: sc
Indication: Hepatitis C
Start date: 2007-07-17
Rebetol
Dosage: po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-01-09
End date: 2007-01-13
Adverse event in 46 year old male receiving Rebetol (Ribavirin)
Reported by a consumer/non-health professional from United States on 2007-07-23
Patient: 46 year old male
Adverse reactions / side effects: Nausea, Retching, Chills, Rectal Haemorrhage, Gastric Ulcer, Haematemesis, Burning Sensation, Haemoglobin Decreased, Arthralgia, Oedema Peripheral, Melaena, Asthenia
Adverse event resulted in: hospitalization
Suspect drug(s):
PEG-Intron
Indication: Hepatitis C
Start date: 2007-04-16
End date: 2007-04-23
Rebetol
Dosage: po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-04-16
End date: 2007-04-23
Adverse event in 57 year old male receiving Rebetol (Ribavirin)
Reported by a physician from United States on 2007-07-23
Patient: 57 year old male
Adverse reactions / side effects: Blood Bilirubin Increased, Vomiting, Nausea, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Dizziness, Motion Sickness
Adverse event resulted in: life threatening event
Suspect drug(s):
PEG-Intron
Dosage: 150 mg;qw;sc
Indication: Hepatitis C
Start date: 2007-02-22
End date: 2007-07-03
Rebetol
Dosage: 1000 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-02-22
End date: 2007-07-03
HCV-796
Dosage: 500 mg;bid;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-02-22
End date: 2007-07-03
Other drugs received by patient: Omeprazole; Allopurinol; Atenolol; Levothyroxine Sodium; Lorazepam; Folic Acid; Fentanyl Transdermal System
Adverse event in 47 year old female receiving Rebetol (Ribavirin)
Reported by a consumer/non-health professional from United States on 2007-07-19
Patient: 47 year old female, weighing 68.0 kg (149.7 pounds)
Adverse reactions / side effects: Chills, Glossitis, Myalgia, Injection Site Erythema, DRY Mouth, Musculoskeletal Stiffness, Blood Alkaline Phosphatase Increased, White Blood Cell Count Decreased, Dyspnoea, Chest Discomfort, Stomatitis, Nausea, Drug Withdrawal Syndrome, Haemoglobin Decreased, Dysgeusia, Dehydration, Blood Creatine Phosphokinase Abnormal, Blood Pressure Fluctuation
Suspect drug(s):
PEG-Intron
Dosage: 96 mcg; sc; 48 mcg; sc
Indication: Hepatitis C
Start date: 2007-04-26
End date: 2007-06-01
Rebetol
Dosage: 1000 mg;qd;po; 600 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-04-26
End date: 2007-06-04
Rebetol
Dosage: 1000 mg;qd;po; 600 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-06-05
Other drugs received by patient: Nexium; Phenergan HCL; Zantac 150; Lyrica
Adverse event in 49 year old female receiving Rebetol (Ribavirin)
Reported by a consumer/non-health professional from United States on 2007-07-18
Patient: 49 year old female
Adverse reactions / side effects: Oral Intake Reduced, Dysphagia, Fatigue, Nausea, Dehydration
Suspect drug(s):
PEG-Intron
Indication: Hepatitis C
Start date: 2007-04-18
Rebetol
Dosage: po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-04-18
Adverse event in 44 year old male receiving Rebetol (Ribavirin)
Reported by a physician from United States on 2007-07-18
Patient: 44 year old male, weighing 86.2 kg (189.6 pounds)
Adverse reactions / side effects: Nasopharyngitis, Visual Acuity Reduced, Headache, Optic Ischaemic Neuropathy, Optic Neuritis, Papilloedema, Walking AID User, Balance Disorder, Blindness Unilateral, Muscle Spasms, Nervousness, Pupillary Reflex Impaired, Back Pain, Visual Field Defect, Acne, Varices Oesophageal, Aggression, Activities of Daily Living Impaired, Anorexia, Otitis Media, Vision Blurred, Neuritis, Purulent Discharge, Optic Atrophy, Xanthopsia, Impaired Driving Ability, Optic Neuropathy, Fatigue, Haematocrit Decreased, RED Blood Cell Count Decreased, Photophobia, Dizziness, Blood Cholesterol Increased, Injury, Depression, Sinusitis, Vomiting, Nausea, Decreased Activity, Scotoma, Eye Pain, Haemoglobin Decreased, Ocular Vascular Disorder, Visual Disturbance, Vertigo, Gliosis, DRY Eye, Drug Dependence, Blindness, Infection, Influenza Like Illness
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
PEG-Intron
Dosage: 120 mcg; qw; sc
Indication: Hepatitis C
Start date: 2002-08-12
End date: 2002-09-16
Rebetol
Dosage: bid; po
Administration route: Oral
Indication: Hepatitis C
Start date: 2002-08-12
End date: 2002-09-16
Other drugs received by patient: Acetaminophen (Prev.); Ibuprofen (Prev.); Methadone (Prev.); Milk Thistle (Con.); Nicotine Resin (Prev.); Nicotine Resin (Prev.); Claritin (Prev.); Penicillin (Prev.); Aspirin (Con.)
Adverse event in 52 year old male receiving Rebetol (Ribavirin)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-07-16
Patient: 52 year old male, weighing 101.6 kg (223.5 pounds)
Adverse reactions / side effects: Abdominal Pain, Vomiting, Haemorrhage, Nausea, Haemoglobin Decreased, Haematocrit Decreased, Diarrhoea, Aspartate Aminotransferase Increased, Platelet Count Decreased, Influenza Like Illness
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Rebetol
Dosage: 1200 mg;qd;po
Administration route: Oral
Indication: Hepatitis C
Infergen
Dosage: 15 mcg;qd;
Indication: Drug USE FOR Unknown Indication
Adverse event in 49 year old male receiving Rebetol (Ribavirin)
Reported by a consumer/non-health professional from United States on 2007-07-11
Patient: 49 year old male, weighing 86.2 kg (189.6 pounds)
Adverse reactions / side effects: Drug Dose Omission, Eye Irritation, Schizophrenia, Headache, Pyrexia, Hyperhidrosis, Delusion, Mania, Fatigue, Thinking Abnormal, Palpitations, Blood Sodium Decreased, Polydipsia, Localised Infection, Vomiting, Mydriasis, Nausea, Laceration, DRY Skin, Convulsion, Bipolar Disorder, Insomnia, Feeling Abnormal
Adverse event resulted in: hospitalization
Suspect drug(s):
PEG-Intron
Dosage: sc
Indication: Hepatitis C
Start date: 2007-04-10
End date: 2007-06-04
Rebetol
Dosage: po
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-04-10
End date: 2007-06-04
Adverse event in male receiving Rebetol (Ribavirin)
Reported by a consumer/non-health professional from United States on 2007-07-09
Patient: male, weighing 83.9 kg (184.6 pounds)
Adverse reactions / side effects: Weight Decreased, Dyspnoea, Respiratory Disorder, Vomiting, Nail Discolouration, Nausea, Anaemia, Incorrect Dose Administered, Skin Discolouration, Dehydration, Apnoea, Influenza Like Illness
Suspect drug(s):
PEG-Intron
Indication: Hepatitis C
End date: 2007-06-20
Rebetol
Dosage: po
Administration route: Oral
Indication: Hepatitis C
End date: 2007-06-20
Other drugs received by patient: Methadone / 00068902 /
Adverse event in 51 year old female receiving Rebetol (Ribavirin)
Reported by a consumer/non-health professional from United States on 2007-07-06
Patient: 51 year old female, weighing 91.2 kg (200.6 pounds)
Adverse reactions / side effects: Contusion, Nasopharyngitis, Headache, Rash Pruritic, Malaise, Lymph Node Pain, Haematoma, Candidiasis, Cardiac Failure Congestive, Dyspnoea, Chest Discomfort, Nausea, Urinary Tract Infection, Anaemia, Anxiety, Burning Sensation, Cardiac Failure, Alopecia, Swelling, Asthenia, Scar, Influenza Like Illness
Adverse event resulted in: hospitalization
Suspect drug(s):
PEG-Intron
Dosage: 120 mcg; qw; sc
Indication: Hepatitis C
Start date: 2007-01-23
End date: 2007-04-16
Rebetol
Dosage: see image
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-01-23
End date: 2007-04-16
Rebetol
Dosage: see image
Administration route: Oral
Indication: Hepatitis C
Start date: 2007-01-23
End date: 2007-04-16
Other drugs received by patient: Accupril; Claritin; Effexor; Inderal; Spiriva
Page 1 Next >>
|
